ITMI950568A0 - Formulazioni farmaceutiche in forma di gel tissotropico - Google Patents

Formulazioni farmaceutiche in forma di gel tissotropico

Info

Publication number
ITMI950568A0
ITMI950568A0 ITMI950568A ITMI950568A ITMI950568A0 IT MI950568 A0 ITMI950568 A0 IT MI950568A0 IT MI950568 A ITMI950568 A IT MI950568A IT MI950568 A ITMI950568 A IT MI950568A IT MI950568 A0 ITMI950568 A0 IT MI950568A0
Authority
IT
Italy
Prior art keywords
pharmaceutical formulations
thixotropic gel
thixotropic
gel
formulations
Prior art date
Application number
ITMI950568A
Other languages
English (en)
Inventor
Luigi Boltri
Maria Antonietta Coppola
Marco Gentile
Gaetano Clavenna
Original Assignee
Dompe
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dompe filed Critical Dompe
Publication of ITMI950568A0 publication Critical patent/ITMI950568A0/it
Priority to IT95MI000568A priority Critical patent/IT1275955B1/it
Priority to ES96104268T priority patent/ES2179133T3/es
Priority to US08/617,205 priority patent/US5858330A/en
Priority to CA002171999A priority patent/CA2171999C/en
Priority to AT96104268T priority patent/ATE219930T1/de
Priority to PT96104268T priority patent/PT733357E/pt
Priority to EP96104268A priority patent/EP0733357B1/en
Priority to DE69622068T priority patent/DE69622068T2/de
Priority to DK96104268T priority patent/DK0733357T3/da
Priority to JP8105995A priority patent/JPH08325164A/ja
Publication of ITMI950568A1 publication Critical patent/ITMI950568A1/it
Application granted granted Critical
Publication of IT1275955B1 publication Critical patent/IT1275955B1/it
Priority to HK98113936A priority patent/HK1012566A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0212Face masks
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/042Gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25Silicon; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
IT95MI000568A 1995-03-22 1995-03-22 Formulazioni farmaceutiche in forma di gel tissotropico IT1275955B1 (it)

Priority Applications (11)

Application Number Priority Date Filing Date Title
IT95MI000568A IT1275955B1 (it) 1995-03-22 1995-03-22 Formulazioni farmaceutiche in forma di gel tissotropico
EP96104268A EP0733357B1 (en) 1995-03-22 1996-03-18 Pharmaceutical formulations in form of thixotropic gel
US08/617,205 US5858330A (en) 1995-03-22 1996-03-18 Pharmaceutical formulations in form of thixotropic gel
CA002171999A CA2171999C (en) 1995-03-22 1996-03-18 Pharmaceutical formulations in form of thixotropic gel
AT96104268T ATE219930T1 (de) 1995-03-22 1996-03-18 Arzneizubereitungen in form eines thixotropen gels
PT96104268T PT733357E (pt) 1995-03-22 1996-03-18 Formulacoes farmaceuticas na forma de gel tixotropico
ES96104268T ES2179133T3 (es) 1995-03-22 1996-03-18 Formaciones farmaceuticas en forma de gel tixotropico.
DE69622068T DE69622068T2 (de) 1995-03-22 1996-03-18 Arzneizubereitungen in Form eines thixotropen Gels
DK96104268T DK0733357T3 (da) 1995-03-22 1996-03-18 Farmaceutiske formuleringer i form af en thixotrop gel
JP8105995A JPH08325164A (ja) 1995-03-22 1996-03-22 チキソトロープゲル状薬剤組成物
HK98113936A HK1012566A1 (en) 1995-03-22 1998-12-17 Pharmaceutical formulations in form of thixotropic gel

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT95MI000568A IT1275955B1 (it) 1995-03-22 1995-03-22 Formulazioni farmaceutiche in forma di gel tissotropico

Publications (3)

Publication Number Publication Date
ITMI950568A0 true ITMI950568A0 (it) 1995-03-22
ITMI950568A1 ITMI950568A1 (it) 1996-09-22
IT1275955B1 IT1275955B1 (it) 1997-10-24

Family

ID=11371015

Family Applications (1)

Application Number Title Priority Date Filing Date
IT95MI000568A IT1275955B1 (it) 1995-03-22 1995-03-22 Formulazioni farmaceutiche in forma di gel tissotropico

Country Status (11)

Country Link
US (1) US5858330A (it)
EP (1) EP0733357B1 (it)
JP (1) JPH08325164A (it)
AT (1) ATE219930T1 (it)
CA (1) CA2171999C (it)
DE (1) DE69622068T2 (it)
DK (1) DK0733357T3 (it)
ES (1) ES2179133T3 (it)
HK (1) HK1012566A1 (it)
IT (1) IT1275955B1 (it)
PT (1) PT733357E (it)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020048596A1 (en) * 1994-12-30 2002-04-25 Gregor Cevc Preparation for the transport of an active substance across barriers
JP3589514B2 (ja) * 1995-09-22 2004-11-17 株式会社ノエビア 非水ゲル状皮膚洗浄料
JP3589513B2 (ja) * 1995-09-22 2004-11-17 株式会社ノエビア マッサージ化粧料
US6103683A (en) * 1996-01-12 2000-08-15 The Procter & Gamble Co. Disinfecting compositions and processes for disinfecting surfaces
US5976573A (en) * 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
AU719836B2 (en) 1997-01-09 2000-05-18 Bifodan A/S Use of dichlorobenzyl alcohol for preparing a preparation for topical treatment of inflammation and a preparation containing dichlorobenzyl alcohol
US5840278A (en) * 1997-02-20 1998-11-24 Coleman; Thomas Nasal spray having a mineral vitamin component, a mineral component and aloe vera
CA2232855C (en) * 1997-04-10 2007-10-09 Roche Consumer Health (Worldwide) Sa Pharmaceutical formulation
DE19717687A1 (de) * 1997-04-28 1998-10-29 Schwarzkopf Gmbh Hans Zubereitung zur Behandlung keratinischer Fasern
GB9718791D0 (en) * 1997-09-05 1997-11-12 Glaxo Group Ltd Medicaments
FR2774290B1 (fr) * 1998-02-05 2000-06-16 Synthelabo Composition pharmaceutique pour l'administration par voie nasale de thiocolchicoside
US20020009478A1 (en) * 1998-08-24 2002-01-24 Douglas Joseph Dobrozsi Oral liquid mucoadhesive compositions
US6319513B1 (en) * 1998-08-24 2001-11-20 The Procter & Gamble Company Oral liquid mucoadhesive compounds
EP1031347B1 (en) 1999-01-27 2002-04-17 Idea Ag Transnasal transport/immunisation with highly adaptable carriers
SI1031346T1 (en) 1999-01-27 2002-08-31 Idea Ag Noninvasive vaccination through the skin
WO2001001962A1 (en) * 1999-07-05 2001-01-11 Idea Ag. A method for the improvement of transport across adaptable semi-permeable barriers
AU2270801A (en) * 1999-12-15 2001-06-25 Donald R. Carter Topical ointment
US6780885B1 (en) * 2000-01-14 2004-08-24 Idexx Laboratories, Inc. Formulations and methods for administration of pharmacologically or biologically active compounds
US6787342B2 (en) * 2000-02-16 2004-09-07 Merial Limited Paste formulations
AU2001248715B2 (en) * 2000-05-08 2005-10-13 Pfizer Products Inc. Skin protectant spray compositions
US6596306B1 (en) * 2000-07-07 2003-07-22 David Ho Sue San Ho Drug delivery system:formulation for fat-soluble drugs
DE10028974A1 (de) * 2000-06-16 2002-01-03 Henkel Kgaa Thixotrope Mund- und Zahnpflegemittel
DE10058224A1 (de) * 2000-11-23 2002-05-29 Henkel Kgaa Treibgasfreie Sprayzubereitungen
DE10064950A1 (de) * 2000-12-23 2002-07-11 Impetus Ag Basel Thixotropes Nasenspray
FR2837102B1 (fr) * 2002-03-18 2004-10-08 Palbian Snc Composition a l'etat de gel aqueux, procede de fabrication et utilisation pour la fabrication d'un medicament, notamment antiherpetique
EP1374856A1 (en) * 2002-06-18 2004-01-02 Impetus AG Oily thixotropic nasal spray
WO2004026263A2 (en) * 2002-09-20 2004-04-01 Fmc Corporation Cosmetic composition containing microcrystalline cellulose
US7473432B2 (en) * 2002-10-11 2009-01-06 Idea Ag NSAID formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery
US7220431B2 (en) 2002-11-27 2007-05-22 Regents Of The University Of Minnesota Methods and compositions for applying pharmacologic agents to the ear
US7811606B2 (en) * 2003-04-16 2010-10-12 Dey, L.P. Nasal pharmaceutical formulations and methods of using the same
US8912174B2 (en) 2003-04-16 2014-12-16 Mylan Pharmaceuticals Inc. Formulations and methods for treating rhinosinusitis
US9808471B2 (en) * 2003-04-16 2017-11-07 Mylan Specialty Lp Nasal pharmaceutical formulations and methods of using the same
US7109247B2 (en) * 2003-05-30 2006-09-19 3M Innovative Properties Company Stabilized particle dispersions containing nanoparticles
US7459146B2 (en) * 2003-05-30 2008-12-02 3M Innovative Properties Company Stabilized aerosol dispersions
US20040242729A1 (en) * 2003-05-30 2004-12-02 3M Innovative Properties Company Stabilized particle dispersions containing surface-modified inorganic nanoparticles
US7704522B2 (en) 2004-09-08 2010-04-27 Clyde Morgan Topical medicament
WO2006050926A2 (en) * 2004-11-12 2006-05-18 Idea Ag Extended surface aggregates in the treatment of skin conditions
MX2007006253A (es) * 2004-11-24 2007-10-18 Anesiva Inc Formulacion de gel de capsaicinoide y usos para esta.
DE102005055385A1 (de) * 2004-12-09 2006-06-14 Bayer Healthcare Ag Arzneimittel zur hygienischen Applikation im Ohr
US20070190190A1 (en) * 2006-02-14 2007-08-16 Ramirez Jose E Conditioning compositions and methods of use thereof
ITMI20060712A1 (it) 2006-04-11 2007-10-12 Fond Irccs Istituto Di Ricovero E Cura ... Uso di aminaftone per la preparazione di un medicamento per il trattamento delle arteriopatie
US20070249546A1 (en) * 2006-04-22 2007-10-25 Sawaya Assad S Ophthalmic and related aqueous solutions containing antifungal agents, uses therefor and methods for preparing them
KR20080076667A (ko) * 2007-02-15 2008-08-20 주식회사 중외제약 요변성 약학 조성물
US10966431B2 (en) 2007-09-11 2021-04-06 Freedom Towel Holdings, LLC. Refreshment towel and applied solution
US8182826B2 (en) * 2007-09-11 2012-05-22 Whitmire A Jeffrey Refreshment towel and applied solution
DE102007055341A1 (de) * 2007-11-19 2009-05-20 Bayer Animal Health Gmbh Stabilisierung öliger Suspensionen enthaltend hydrophobe Kieselsäuren
WO2012053012A2 (en) * 2010-10-21 2012-04-26 Cadila Healthcare Limited Topical pharmaceutical compositions comprising tfflocolchicoside
MD4291C1 (ro) * 2013-12-27 2015-02-28 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Preparat medicamentos pentru tratamentul otitelor
PE20161173A1 (es) 2014-02-10 2016-10-27 Troikaa Pharmaceuticals Ltd Formulaciones topicas de la heparina
FR3083093A1 (fr) * 2018-06-28 2020-01-03 L'oreal Composition photoprotectrice comprenant des particules de silice colloidale
GB2593712A (en) * 2020-03-30 2021-10-06 Regen Lab Sa Viral infections - treatment with convalescent plasma /serum

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1572032A (en) * 1977-01-31 1980-07-23 Hoechst Uk Ltd Gels comprising silica and an aqueous acid
US4996240A (en) * 1986-05-28 1991-02-26 Osipow Lloyd I Synthetic polymer propellant systems
US4992256A (en) * 1989-09-27 1991-02-12 Colgate-Palmolive Company Plaque disclosing compositions
US5214035A (en) * 1992-04-16 1993-05-25 Hoechst-Roussel Agri-Vet Company Thixotropic formulations

Also Published As

Publication number Publication date
CA2171999C (en) 2008-05-20
ES2179133T3 (es) 2003-01-16
HK1012566A1 (en) 1999-08-06
EP0733357A1 (en) 1996-09-25
DE69622068T2 (de) 2003-01-30
IT1275955B1 (it) 1997-10-24
JPH08325164A (ja) 1996-12-10
ITMI950568A1 (it) 1996-09-22
PT733357E (pt) 2002-11-29
CA2171999A1 (en) 1996-09-23
US5858330A (en) 1999-01-12
DE69622068D1 (de) 2002-08-08
ATE219930T1 (de) 2002-07-15
DK0733357T3 (da) 2002-10-28
EP0733357B1 (en) 2002-07-03

Similar Documents

Publication Publication Date Title
ITMI950568A0 (it) Formulazioni farmaceutiche in forma di gel tissotropico
BR9610153A (pt) Formulações farmacêuticas
BR9611626A (pt) Formulações farmacéuticas
BR9611367A (pt) Formulação farmacêutic liofilizada estável
DK1093815T3 (da) Oral 2-methyl-thieno-benzodiazepinformulering
NO20004345D0 (no) Farmasøytisk sammensetning
ID24654A (id) Formulasi farmasi omeprazola
NO954486D0 (no) Farmasöytiske formuleringsgrunnlag
PT769965E (pt) Formulacoes aquosas de risperidona
BR9610396A (pt) Formulação farmacêutica
ITMI930605A0 (it) Formulazioni orali di ubidecarenone in forma di capsule
ITMI951395A0 (it) Formulazioni di f-silicone
ID16781A (id) Formulasi-formulasi farmasi
DE69629457D1 (de) Impfstoff in gelform
DE69614407T2 (de) Pharmazeutische zusammensetzungen
LV11727A (lv) Farmaceitiska kompozicija
BR9507768A (pt) Composição farmacêutica
ITMI941169A0 (it) Formulazioni farmaceutiche
FI973280A (fi) Farmaseuttinen koostumus
ITMI942166A0 (it) Composizioni farmaceutiche miorilassanti
FI973230A (fi) Uusi farmaseuttinen formulaatio
IT237237Y1 (it) Disposizione di collegamento nella costruzione di automobili
BR9606066A (pt) Composto e formulação farmacêutica
BR9605777A (pt) Composição farmacêutica
FI962738A0 (fi) Farmaseuttiset koostumukset

Legal Events

Date Code Title Description
0001 Granted